moderna
Latest
Hitting the Books: How Moderna dialed-in its vaccine to fight COVID's variants
In "The Messenger," veteran reporter Peter Loftus takes readers through the harrowing days of 2020 as COVID-19 raged across the globe and biotech startup Moderna raced to create a vaccine to halt the viral rampage.
Moderna begins early-stage trials of mRNA-based HIV vaccine
Moderna has begun early-stage clinical trials of an HIV mRNA vaccine,
Moderna enters clinical trials for its mRNA-based flu vaccine
Moderna has injected its mRNA-derived vaccine for the seasonal flu into a human volunteer for the first time as part of a Phase 1/2 clinical study, the company announced on Wednesday.
How the world went from no COVID vaccines to two in under a year
The next stage involves testing the vaccine on animals. By November, just four months after beginning phase III trials, the company demonstrated its vaccine to be 94 percent effective in preventing COVID infection.